ENVVENO MEDICAL CORPORATION
70 Doppler
Irvine, California 92618
November 1, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
| Re: | enVVeno Medical Corporation | ||
| Registration Statement on Form S-3 | |||
| Filed October 26, 2023 | |||
| File No. 333-275187 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. EST on Friday, November 3, 2023, or as soon as thereafter practicable.
| Very truly yours, | |
| /s/ Robert Berman | |
| Robert Berman | |
| Chief Executive Officer |
| cc: | Ellenoff Grossman & Schole LLP |
